Companies / Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc.
DCPHCIK 1654151
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 24, 2023 | Brightstar Associates LLC 10% owner | Buy Open-market buy | Common Stock | $30.00M | +1.7M +9.23% | 19,718,014 | high |
| Apr 29, 2022 | Brightstar Associates LLC 10% owner | Buy Open-market buy | Common Stock | $14.79M | +1.5M +8.92% | 18,051,348 | high |
| Jan 4, 2021 | Taylor Michael Douglas Director | Sell Open-market sale | Common Stock | $483.2K | -9K -75.30% | 2,794 | medium |
| Feb 14, 2023 | Hoerter Steven L. CEO | Sell Open-market sale | Common Stock | $480.7K | -30K -80.02% | 7,500 | medium |
| Dec 13, 2023 | Hoerter Steven L. CEO | Sell Open-market sale | Common Stock | $471.2K | -31K -29.65% | 72,763 | medium |
| Jan 4, 2021 | Taylor Michael Douglas Director | Sell Open-market sale | Common Stock | $429.0K | -8K -40.47% | 11,311 | medium |
| Apr 12, 2021 | Bristol James Arthur Director | Sell Open-market sale | Common Stock | $414.4K | -9K -64.51% | 5,217 | medium |
| May 3, 2021 | Taylor Michael Douglas Director | Sell Open-market sale | Common Stock | $354.7K | -8K -96.25% | 300 | medium |